Nefazodone hydrochloride, >=98% (HPLC), solid

Nefazodone hydrochloride, >=98% (HPLC), solid

Biochem/physiol Actions

Novel antidepressant; mixed 5-HT2A serotonin receptor antagonist/serotonin uptake inhibitor.

Features and Benefits

This compound was developed by Bristol-Myers Squibb. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Packaging

10, 50 mg in glass bottle

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Colour Quality Level InChI key InChI Manufacturer Form Assay Price Quantity
3573500 Nefazodone hydrochloride, >=98% (HPLC), solid white 100 DYCKFEBIOUQECE-UHFFFAOYSA-N 1S/C25H32ClN5O2.ClH/c1-2-24-27-31(25(32)30(24)18-19-33-23-10-4-3-5-11-23)13-7-12-28-14-16-29(17-15-28)22-9-6-8-21(26)20-22;/h3-6,8-11,20H,2,7,12-19H2,1H3;1H
£196.39 (exc VAT) per 10MG
-
+
3573501 Nefazodone hydrochloride, >=98% (HPLC), solid white 100 DYCKFEBIOUQECE-UHFFFAOYSA-N 1S/C25H32ClN5O2.ClH/c1-2-24-27-31(25(32)30(24)18-19-33-23-10-4-3-5-11-23)13-7-12-28-14-16-29(17-15-28)22-9-6-8-21(26)20-22;/h3-6,8-11,20H,2,7,12-19H2,1H3;1H
£784.18 (exc VAT) per 50MG
-
+